SAVA logo

Cassava Sciences (SAVA) Company Overview

Profile

Full Name:

Cassava Sciences, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 14, 2000

Indexes:

Not included

Description:

Cassava Sciences, also known as SAVA, is a biotechnology company focused on developing treatments for neurodegenerative diseases, particularly Alzheimer's. They aim to create innovative therapies that improve brain health and cognitive function, using advanced science and research to address these challenging conditions.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Dec 13, 2012
Splits

Next split:

N/A

Recent split:

May 10, 2017

Analyst ratings

Recent major analysts updates

Mar 4, 25 HC Wainwright & Co.
Neutral
Nov 26, 24 HC Wainwright & Co.
Neutral
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 8, 24 HC Wainwright & Co.
Buy
Aug 13, 24 HC Wainwright & Co.
Neutral
Aug 8, 24 Rodman & Renshaw
Buy
Jul 19, 24 HC Wainwright & Co.
Neutral
Jul 1, 24 Jones Trading
Hold
Jul 1, 24 HC Wainwright & Co.
Neutral
May 17, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Cassava Sciences?
  • Does Cassava Sciences pay dividends?
  • What sector is Cassava Sciences in?
  • What industry is Cassava Sciences in?
  • What country is Cassava Sciences based in?
  • When did Cassava Sciences go public?
  • Is Cassava Sciences in the S&P 500?
  • Is Cassava Sciences in the NASDAQ 100?
  • Is Cassava Sciences in the Dow Jones?
  • When was Cassava Sciences's last earnings report?
  • When does Cassava Sciences report earnings?
  • Should I buy Cassava Sciences stock now?

What is the ticker symbol for Cassava Sciences?

The ticker symbol for Cassava Sciences is NASDAQ:SAVA

Does Cassava Sciences pay dividends?

No, Cassava Sciences does not pay dividends

What sector is Cassava Sciences in?

Cassava Sciences is in the Healthcare sector

What industry is Cassava Sciences in?

Cassava Sciences is in the Biotechnology industry

What country is Cassava Sciences based in?

Cassava Sciences is headquartered in United States

When did Cassava Sciences go public?

Cassava Sciences's initial public offering (IPO) was on July 14, 2000

Is Cassava Sciences in the S&P 500?

No, Cassava Sciences is not included in the S&P 500 index

Is Cassava Sciences in the NASDAQ 100?

No, Cassava Sciences is not included in the NASDAQ 100 index

Is Cassava Sciences in the Dow Jones?

No, Cassava Sciences is not included in the Dow Jones index

When was Cassava Sciences's last earnings report?

Cassava Sciences's most recent earnings report was on Feb 28, 2025

When does Cassava Sciences report earnings?

The date for Cassava Sciences's next earnings report has not been announced yet

Should I buy Cassava Sciences stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions